Matches in SemOpenAlex for { <https://semopenalex.org/work/W2550991966> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2550991966 abstract "Abstract Anthracyclines, especially daunorubicin, play a very important role in the treatment of acute lymphoblastic leukemia (ALL) and the relapsed ALL in childhood. In the present study, primary lymphoblasts isolated from 65 children with de novo ALL (median: 5.8 years; range: 1.9 – 16.9 years) and relapsed ALL (median: 12.7 years; range: 1.3 – 17.9 years) were treated with daunorubicin (10 mmol/l) or idarubicin (2 mmol/l) in vitro. We could show that both anthracylines induce apoptosis, as evidenced by measurement of genomic DNA fragmentation. Interestingly, daunorubicin only induced modest apoptosis, whereas idarubicin displayed a significantly stronger apoptosis inducing effect. Furthermore the treatment of daunorubicin-resistant lymphoblasts with idarubicin resulted in good response in most of the resistant cell populations. Out of the 65 patients analysed in this study 23 were female (13 de novo ALL, 10 relapsed ALL) and 42 were male (29 de novo ALL, 13 relapsed ALL). Primary lymphoblasts were obtained by bone marrow aspiration and separated by centrifugation over Ficoll. Within these cell populations following immunologic subgroups were found: 35 c-ALL, 10 pre-B-ALL, 7 pro-B-ALL, 10 T-ALL and 3 pre-T-ALL. Daunorubicin induced apoptosis in 33 out of 65 lymphoblast populations (response rate 50.8 %). Nevertheless, a far higher response rate was observed for idarubicin with 59/65 (90,8 %) (p < 0.008), if response is defined as apoptosis induction higher than 1 %. Daunorubicin-resistance was found in 32/65 (49,2 %), resistance to both was observed in 6/65 (9,2 %). Treatment of daunorubicin-resistant lymphoblasts with idarubicin resulted in significant apoptosis induction in 26 out of 32 cell populations (81,3 %). We clearly demonstrated here that the in vitro treatment of lymphoblasts from children with de novo or relapsed ALL with idarubicin induces significantly higher response rates than daunorubicin treatment. The ex vivo sensitivity of daunorubicin-resistant lymphoblasts of childhood ALL to idarubicin treatment reflects the better potency of idarubicin to induce apoptosis and to overcome daunorubicin resistance. These data prompted us to study the clinical relevance of idarubicin in ongoing clinical trials to improve existing therapeutic regiments. First clinical data point to a good tolerability of idarubicin in the treatment of relapsed ALL in childhood." @default.
- W2550991966 created "2016-11-30" @default.
- W2550991966 creator A5005184673 @default.
- W2550991966 creator A5010332111 @default.
- W2550991966 creator A5039656345 @default.
- W2550991966 creator A5042026867 @default.
- W2550991966 creator A5047629043 @default.
- W2550991966 creator A5061900764 @default.
- W2550991966 creator A5073379037 @default.
- W2550991966 creator A5076690169 @default.
- W2550991966 creator A5086586881 @default.
- W2550991966 date "2004-11-16" @default.
- W2550991966 modified "2023-10-16" @default.
- W2550991966 title "Sensitivity of Childhood Acute Lymphoblastic Leukemia (ALL) to Idarubicin Is Significantly Higher Than to Daunorubicin Treatment Based on Ex Vivo Apoptosis Induction." @default.
- W2550991966 doi "https://doi.org/10.1182/blood.v104.11.4495.4495" @default.
- W2550991966 hasPublicationYear "2004" @default.
- W2550991966 type Work @default.
- W2550991966 sameAs 2550991966 @default.
- W2550991966 citedByCount "0" @default.
- W2550991966 crossrefType "journal-article" @default.
- W2550991966 hasAuthorship W2550991966A5005184673 @default.
- W2550991966 hasAuthorship W2550991966A5010332111 @default.
- W2550991966 hasAuthorship W2550991966A5039656345 @default.
- W2550991966 hasAuthorship W2550991966A5042026867 @default.
- W2550991966 hasAuthorship W2550991966A5047629043 @default.
- W2550991966 hasAuthorship W2550991966A5061900764 @default.
- W2550991966 hasAuthorship W2550991966A5073379037 @default.
- W2550991966 hasAuthorship W2550991966A5076690169 @default.
- W2550991966 hasAuthorship W2550991966A5086586881 @default.
- W2550991966 hasConcept C113842279 @default.
- W2550991966 hasConcept C126322002 @default.
- W2550991966 hasConcept C190283241 @default.
- W2550991966 hasConcept C202751555 @default.
- W2550991966 hasConcept C203014093 @default.
- W2550991966 hasConcept C26291073 @default.
- W2550991966 hasConcept C2778041864 @default.
- W2550991966 hasConcept C2778461978 @default.
- W2550991966 hasConcept C2779117419 @default.
- W2550991966 hasConcept C2781021840 @default.
- W2550991966 hasConcept C2781107101 @default.
- W2550991966 hasConcept C2909962599 @default.
- W2550991966 hasConcept C54355233 @default.
- W2550991966 hasConcept C55493867 @default.
- W2550991966 hasConcept C71924100 @default.
- W2550991966 hasConcept C81885089 @default.
- W2550991966 hasConcept C86803240 @default.
- W2550991966 hasConceptScore W2550991966C113842279 @default.
- W2550991966 hasConceptScore W2550991966C126322002 @default.
- W2550991966 hasConceptScore W2550991966C190283241 @default.
- W2550991966 hasConceptScore W2550991966C202751555 @default.
- W2550991966 hasConceptScore W2550991966C203014093 @default.
- W2550991966 hasConceptScore W2550991966C26291073 @default.
- W2550991966 hasConceptScore W2550991966C2778041864 @default.
- W2550991966 hasConceptScore W2550991966C2778461978 @default.
- W2550991966 hasConceptScore W2550991966C2779117419 @default.
- W2550991966 hasConceptScore W2550991966C2781021840 @default.
- W2550991966 hasConceptScore W2550991966C2781107101 @default.
- W2550991966 hasConceptScore W2550991966C2909962599 @default.
- W2550991966 hasConceptScore W2550991966C54355233 @default.
- W2550991966 hasConceptScore W2550991966C55493867 @default.
- W2550991966 hasConceptScore W2550991966C71924100 @default.
- W2550991966 hasConceptScore W2550991966C81885089 @default.
- W2550991966 hasConceptScore W2550991966C86803240 @default.
- W2550991966 hasLocation W25509919661 @default.
- W2550991966 hasOpenAccess W2550991966 @default.
- W2550991966 hasPrimaryLocation W25509919661 @default.
- W2550991966 hasRelatedWork W191705085 @default.
- W2550991966 hasRelatedWork W1977644172 @default.
- W2550991966 hasRelatedWork W2031603496 @default.
- W2550991966 hasRelatedWork W2325331777 @default.
- W2550991966 hasRelatedWork W2333196452 @default.
- W2550991966 hasRelatedWork W2353528100 @default.
- W2550991966 hasRelatedWork W2398527109 @default.
- W2550991966 hasRelatedWork W2550991966 @default.
- W2550991966 hasRelatedWork W2577061219 @default.
- W2550991966 hasRelatedWork W3031185126 @default.
- W2550991966 isParatext "false" @default.
- W2550991966 isRetracted "false" @default.
- W2550991966 magId "2550991966" @default.
- W2550991966 workType "article" @default.